Chikungunya virus (CHIKV), formerly only an anecdotally described arbovirus, is now a worldwide public health problem ([@R1]). Recently, numerous cases of CHIKV infection have been reported from a major outbreak of febrile illness around the Indian Ocean, which included Comoros, Mauritius, Réunion Island ([@R2],[@R3]), and southern India ([@R4]).

CHIKV is widely distributed in tropical Africa ([@R5],[@R6]) and in Asia ([@R7]). In Africa, until 2000, the virus was described as endemic, perpetuated through a sylvatic cycle involving wild primates, humans, and mosquitoes of the genus *Aedes* ([@R8],[@R2]). During the past 6 years, the urban cycle has also tended to play a role in Central Africa ([@R6]). Nevertheless, although recent serologic surveys suggest a high prevalence of *Togaviridae*, *Flaviviridae,* and *Bunyaviridae* ([@R9],[@R10]), understanding of the circulation and effects of arboviruses in Cameroon remains imprecise. This lack of understanding may reflect confusion between arboviral infections and hyperendemic *Plasmodium falciparum* infection.

We report the first isolation, to our knowledge, of CHIKV in Cameroon. The virus was identified during an outbreak of a febrile syndrome in French soldiers in Douala and in patients from an urban medical center in Yaoundé. We also found evidence of cocirculation of CHIKV and dengue virus (DENV).

The Study
=========

In Douala, Cameroon, 2 sporadic cases of a denguelike syndrome were recorded in French soldiers (patients 1 and 2) on April 3 and May 22, 2006, respectively ([Table](#T1){ref-type="table"}). From the end of May through the end of July 2006, more cases of denguelike syndrome, which included fever, asthenia, maculopapular rashes, and arthralgia, were observed in Yaoundé. The number of patients who sought treatment at the Yaoundé Medical Center peaked in mid-June 2006. Blood samples were collected from 30 of the 40 patients who visited the medical center. The 30 patients' ages ranged from 1 to 54 years. The delay between the onset of symptoms and the sampling ranged from 0 to 39 days with a median of 4 days ([Table](#T1){ref-type="table"}). All but 1 patient lived in Yaoundé, and none of these patients had a history of travel abroad or from Yaoundé. Nine patients were Cameroonian, and all other patients were from other countries; 15 patients were female. A blood sample from a 53-year-old woman who returned to France from Yaoundé was also received. All patients had negative results for *P. falciparum* according to rapid test (Core Malaria Pf, Core Diagnostics, Birmingham, UK) and thick smear examination.

###### Characteristics of patients with febrile acute denguelike syndrome, Cameroon, 2006\*

  Patient no.   Sex/age   City            Symptom onset   Sampling date   Delay, days   IgM†        IgG†                  PCR‡
  ------------- --------- --------------- --------------- --------------- ------------- ----------- --------------------- ----------
  1             M/35      Douala          3 Apr           7 Apr           4             Neg         Neg                   Neg
  1             M/35      Douala          3 Apr           11 May          21            Pos CHIK    Pos CHIKV             Neg
  2§            M/36      Douala          22 May          23 May          1             Neg         Neg                   Pos CHIK
  3             F/54      Yaoundé         11 Jun          12 Jun          1             Neg         Neg                   Neg
  4             F/49      Yaoundé         10 Jun          13 Jun          3             Neg         Neg                   Neg
  5             F/42      Yaoundé         11 Jun          12 Jun          1             Neg         Neg                   Neg
  6             F/41      Yaoundé         7 Jun           7 Jun           0             Neg         Pos Flavi             Neg
  7             M/38      Yaoundé         15 Jun          19 Jun          4             Neg         Neg                   Neg
  8             M/30      Yaoundé         18 Aug          19 Jun          1             Neg         Neg                   Neg
  9             M/21      Yaoundé         15 Jun          19 Jun          4             Neg         Neg                   Neg
  10            F/32      Yaoundé         21 Jun          22 Jun          1             Neg         Neg                   Neg
  11            F/22      Yaoundé         19 Jun          26 Jun          7             Pos CHIKV   Neg                   Neg
  12            F/53      Imported case   20 Jun          26 Jun          6             Pos CHIKV   Pos CHIK              Neg
  13            M/42      Yaoundé         24 Jun          27 Jun          3             Neg         Pos Flavi             Neg
  14            F/42      Yaoundé         18 Jun          28 Jun          10            Neg         Neg                   Neg
  15            F/27      Yaoundé         18 Jun          29 Jun          11            Neg         Pos Flavi             Neg
  16            F/43      Yaoundé         26 Jun          30 Jun          4             Neg         Neg                   Neg
  17            M/31      Yaoundé         16 Jun          30 Jun          14            Neg         Neg                   Neg
  18            F/37      Yaoundé         22 May          30 Jun          39            Pos CHIK    Pos CHIK              Neg
  19            F/45      Yaoundé         10 Jun          30 Jun          20            Neg         Neg                   Neg
  20            M/45      Yaoundé         22 Jun          30 Jun          8             Neg         Pos Flavi and CHIKV   Neg
  21            M/1       Yaoundé         23 Jun          30 Jun          7             Neg         Neg                   Neg
  22            F/9       Yaoundé         10 Jun          30 Jun          20            Neg         Neg                   Neg
  23            M/4       Yaoundé         26 Jun          30 Jun          4             Neg         Neg                   Neg
  24            M/54      Yaoundé         4 Jul           6 Jul           2             Neg         Neg                   Neg
  25            F/45      Yaoundé         14 Jun          5 Jul           21            Neg         Neg                   Neg
  26            M/48      Yaoundé         24 Jun          6 Jul           12            Neg         Neg                   Neg
  27            M/20      Yaoundé         30 Jun          1 Jul           1             Neg         Neg                   Neg
  28            M/37      Yaoundé         4 Jul           11 Jul          7             Pos CHIK    Pos CHIKV             Neg
  29            M/36      Yaoundé         9 Jul           11 Jul          2             Neg         Neg                   Neg
  30            M/33      Yaoundé         28 Jun          10 Jul          12            Neg         Neg                   Neg
  31            M/32      Yaoundé         10 Jul          12 Jul          2             Neg         Neg                   Pos DENV
  32            F/38      Yaoundé         16 Jul          17 Jul          1             Neg         Neg                   Neg
  33            M/45      Yaoundé         21 Jul          26 Jul          5             Neg         Neg                   Neg

\*IgM, immunoglobulin M; Neg, negative; Pos, positive; CHIKV, chikungunya virus; Flavi, flavivirus; DENV, dengue virus. †CHIKV isolation successful. ‡DENV, West Nile virus, Wesselsbron virus, Rift Valley fever virus, Bunyamwera virus, and CHIKV antibodies tested. §DENV, West Nile virus, CHIKV tested by real-time RT-PCR.

Serum specimens were tested for immunoglobulin M (IgM) and IgG antibodies specific for DENV, West Nile virus (WNV), Wesselsbron virus, Rift Valley fever virus, Bunyamwera virus, and CHIKV by IgM-antibody capture (MAC-ELISA) and IgG sandwich ELISA, respectively ([@R11]). A serum sample was consider positive if the optical density (OD) ratio of viral antigen to uninfected cells was \>3. The presence of CHIKV, DENV, and WNV genomes was tested for by specific real-time reverse transcription PCR (RT-PCR) ([@R12]). Virus isolation on C6/36 and Vero cells was attempted on samples that were positive by RT-PCR ([@R11]).

The serologic follow up of patient 1 ([Table](#T1){ref-type="table"}) for a 3-week period detected seroconversion to a virus antigenically related to CHIKV virus (the OD ratios obtained with the second sample were \>3) for IgM and IgG. A sample from patient 2 was obtained the day after the onset of symptoms, and no antibodies to all tested arboviruses were detected. However, the specimen was positive by real-time RT-PCR for CHIKV. The patient's sample yielded CHIKV when cultured, and the envelope gene was partially sequenced (position 10,238--11,367, GenBank accession no. Bankit851776). The 1.2-kb sequence genetic analysis did not show any codon deletion or insertion when compared with other African CHIKV sequences available in the GenBank database ([@R3],[@R6],[@R8]). A high degree of identity was observed when the sequence was compared with the Democratic Republic of the Congo (DRC) strains isolated in 2000 ([@R6]). Paired identity ranged from 97% to 98.1% at the nucleotide level and from 98.7% to 99.3% at the amino acid level. The Cameroon isolate displayed a higher nucleotide divergence (paired identity ranging from 95% to 95.5%) when compared with the 2006 Réunion Island strains ([@R2],[@R3],[@R13]). However, amino acid sequences were highly conserved (99%--99.5%). The sequence identity among these isolates highlights their common origin and particularly the genetic stability of CHIKV despite the 6 years and the geographic distance from the DRC outbreaks. As shown in the phylogenetic tree ([Figure](#F1){ref-type="fig"}), the CHIKV Cameroon strain clustered with DRC CHIKV strains with a high bootstrap value of 100. This genotype of CHIKV was closely related to strains from the Central African Republic and the 1982 Uganda isolate ([@R6],[@R8]). The close genetic relationship suggests a continuous circulation of a homologous CHIKV population in Central Africa with a high degree of genetic stability. The genetic stability of the Central African CHIKV strains during 24 years, whether associated with epidemic or sporadic cases, highlights the peculiar importance of the few mutations detected in the recent Réunion Island isolates ([@R3]). This also suggests that the Central African strain CHIKV zone of circulation now includes India ([@R4]), the Indian Ocean, and Cameroon.
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The phylogenetic tree also illustrates the differences between the Cameroon isolates and the Asian subgroup isolates. Moreover, when compared with Asian CHIKV, including the 2006 isolates, the Cameroon strain showed 91%--91.9% and 96.8%--98.8% identity at the nucleotide and amino acid levels, respectively. Despite the similarity, cross-neutralization experiments must be conducted to confirm the protective effect of the Asian CHIKV-based vaccine against Central African strains ([@R2]).

Among patients from Yaoundé, 1 (patient 11) had only IgM antibodies specific to CHIKV, while patients 18 and 28 had both IgM and IgG antibodies specific to CHIKV ([Table](#T1){ref-type="table"}). One patient from Cameroon (patient 20) had IgG specific to both CHIKV and flavivirus. Three patients (nos. 6, 13, and 15), 2 of whom were Cameroonian, had antibodies specific for flavivirus. All samples were negative for WNV and CHIKV by RT-PCR. One sample (from patient 31) was positive for DENV; however, no virus was detected by cell culture. These results suggested a cocirculation of CHIKV and dengue virus during the same period, which is consistent with the suspected circulation of dengue virus, CHIKV, and yellow fever virus observed in a study from 2000 through 2003 in Cameroon ([@R9]).

In Cameroon, as in DRC ([@R6]), patients were likely infected in urban or periurban centers (Yaoundé, the capital of Cameroon; Douala, a major city). These infections occurred in a context where *Aedes albopictus* tends to replace indigenous *Ae. aegypti* in rural and urban Cameroonian environments ([@R14]). This finding suggests that urban cycles and urban vectors, in addition to the traditional forest-dwelling vectors, may play an important role in the maintenance and amplification of CHIKV in Africa.

Conclusions
===========

Since its first isolation in 1953 ([@R8]), CHIKV has been isolated in different Central African countries ([@R8],[@R6]). Until now, only 2 alphavirus strains antigenically suspected to be CHIKV had been isolated from human patients in Cameroon ([@R15]). Recent serosurvey studies suggested a possible CHIKV circulation in Cameroon ([@R9],[@R10]). Our Cameroon CHIKV isolate confirmed its circulation in this country. Our study suggests a 6-year continuous circulation of genetically stable and indigenous strains in Central Africa rather than importation of CHIKV from the recent Indian Ocean or Asian outbreaks. Moreover, the genetic stability of the Central African CHIKV highlights the importance of the unique molecular features that was shown in Réunion Island isolates ([@R3]).

Suggested citation: Peyrefitte CN, Rousset D, Pastorino BAM, Pouillot R, Bessaud M, Tock F, et al. Chikungunya virus, Cameroon, 2006. Emerg Infect Dis \[serial on the Internet\]. 2007 May \[*date cited*\]. Available from <http://www.cdc.gov/eid/content/13/5/768.htm>

We are indebted to Jon Davis for manuscript revision.

Dr Peyrefitte is involved in the diagnosis and epidemiology of arboviruses. He also researches arbovirus-cell interactions.
